A new discovery by scientists at the University of Edinburgh as part of a study that was published in Nature Medicine journal, patients struggling with inflammatory conditions such as chronic diseases of the lung, joints and other organs can now expect great relief.

This study suggested how certain drugs, already tested as cancer treatment options may reduce the level of tissue inflammation.

From News-Medical.Net:

Professor Chris Haslett, Head of the Queen’s Medical Research Institute at the University of Edinburgh, expects the study to lead to trials of these drugs in human inflammatory diseases. Professors Adriano Rossi and Haslett, who have led this new study with other colleagues from the QMRI, said: “This study offers new hope for patients with severe inflammatory diseases. Specific treatment for such conditions is poor, and the use of steroids is fraught with potential difficulties. We have adopted a different strategy by using non-biological treatments, but this study needs urgently to be translated into trials and we are now seeking major funding to research further how these drugs work.”

It is worthwhile to note here that lab tests have highlighted the fact that CDK inhibitors, like Roscovitine, can significantly minimize the inflammation level in models of rheumatoid arthritis and the fatal ailment called fibrosing alveolitis.

No Comments »

No comments yet.

RSS feed for comments on this post. TrackBack URL

Leave a comment

You must be logged in to post a comment.